1. bookTom 64 (2018): Zeszyt 4 (December 2018)
Informacje o czasopiśmie
License
Format
Czasopismo
eISSN
2449-8343
Pierwsze wydanie
04 Apr 2014
Częstotliwość wydawania
4 razy w roku
Języki
Angielski
Otwarty dostęp

Berberis vulgaris alleviates Levodopa-induced dyskinesia in male mice

Data publikacji: 04 Mar 2019
Tom & Zeszyt: Tom 64 (2018) - Zeszyt 4 (December 2018)
Zakres stron: 44 - 49
Otrzymano: 14 Feb 2018
Przyjęty: 10 Sep 2018
Informacje o czasopiśmie
License
Format
Czasopismo
eISSN
2449-8343
Pierwsze wydanie
04 Apr 2014
Częstotliwość wydawania
4 razy w roku
Języki
Angielski

1. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56(1):33-9.10.1001/archneur.56.1.33Search in Google Scholar

2. Fisone G, Bezard E. Molecular mechanisms of L-DOPA-induced dyskinesia. Int Rev Neurobiol 2011; 98:95-122. doi: http://dx.doi.org/10.1016/B978-0-12-381328-2.00004-310.1016/B978-0-12-381328-2.00004-3Search in Google Scholar

3. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Movement Dis 2010; 25(15):2649-53. doi: http://dx.doi.org/10.1002/mds.2342910.1002/mds.23429Search in Google Scholar

4. Luginger E, Wenning G, Bösch S, Poewe W. Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson’s disease. Movement Dis 2000; 15(5):873-8.10.1002/1531-8257(200009)15:5<873::AID-MDS1017>3.0.CO;2-ISearch in Google Scholar

5. Calixto J. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Brazilian J Med Biol Res 2000; 33(2):179-89.10.1590/S0100-879X2000000200004Search in Google Scholar

6. Rahimi-Madiseh M, Lorigoini Z, Zamani-Gharaghoshi H, Rafieian-Kopaei M. Berberis vulgaris: specifications and traditional uses. Iran J Basic Med Sci 2017; 20(5):569-87. doi: http://dx.doi.org/10.22038/IJBMS.2017.8690Search in Google Scholar

7. Schober A. Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP. Cell Tiss Res 2004; 318(1):215-24. doi: http://dx.doi.org/10.1007/s00441-004-0938-y10.1007/s00441-004-0938-ySearch in Google Scholar

8. Lee CS, Cenci MA, Schulzer M, Björklund A. Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson’s disease. Brain 2000; 123(7):1365-79.10.1093/brain/123.7.1365Search in Google Scholar

9. Paquette MA, Anderson AM, Lewis JR, Meshul CK, Johnson SW, Berger SP. MK-801 inhibits LDOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism. Neuropharmacology 2010; 58(7):1002-8. doi: http://dx.doi.org/10.1016/j.neuropharm.2010.01.00310.1016/j.neuropharm.2010.01.003Search in Google Scholar

10. Ardestani SB, Sahari MA, Barzegar M, Abbasi S. Some physicochemical properties of Iranian native barberry fruits (abi and poloei): Berberis integerrima and Berberis vulgaris. J Food Pharm Sci 2013;1(3). doi: http://dx.doi.org/10.15835/nbha4621111110.15835/nbha46211111Search in Google Scholar

11. Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Health Persp 2001; 109(Suppl 1):69.10.1289/ehp.01109s169Search in Google Scholar

12. Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 2008; 22(8):999-1012. doi: http://dx.doi.org/10.1002/ptr.239910.1002/ptr.239918618524Search in Google Scholar

13. El-Wahab AEA, Ghareeb DA, Sarhan EE, Abu-Serie MM, El Demellawy MA. In vitro biological assessment of Berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects. BMC Complem Alt Med 2013; 13(1):218. http://dx.doi.org/10.1186/1472-6882-13-21810.1186/1472-6882-13-218401655024007270Search in Google Scholar

14. Jiang W, Li S, Li X. Therapeutic potential of berberine against neurodegenerative diseases. Sci China Life Sci 2015; 58(6):564-9. http://dx.doi.org/10.1007/s11427-015-4829-010.1007/s11427-015-4829-0582353625749423Search in Google Scholar

15. Ahmed T, Abdollahi M, Daglia M, Nabavi SF, Nabavi SM. Berberine and neurodegeneration: A review of literature. Pharmacol Rep 2015; 67(5):970-9. doi: http://dx.doi.org/10.1016/j.pharep.2015.03.00210.1016/j.pharep.2015.03.00226398393Search in Google Scholar

16. Kim M, Cho K-H, Shin M-S, Lee J-M, Cho H-S, Kim C-J, et al. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson’s disease. Intern J Mol Med 2014; 33(4):870-8. doi: http://dx.doi.org/10.3892/ijmm.2014.165610.3892/ijmm.2014.165624535622Search in Google Scholar

17. Salar F, Ziai S, Nasri S, Roghani M, Kamalinejad M. Neuroprotective effect of aqueous extract of Berberis vulgaris L. in a model of Parkinson’s disease in rat. J Med Plants 2010; 9(36):24-216.Search in Google Scholar

18. Thanvi B, Lo N, Robinson T. Levodopa-induced dyskinesia in Parkinson’s disease: clinical features, pathogenesis, prevention and treatment. Postgrad Med J 2007; 83(980):384-8. doi: http://dx.doi.org/10.1136/pgmj.2006.05475910.1136/pgmj.2006.054759260005217551069Search in Google Scholar

19. Ming M, Sinnett-Smith J, Wang J, Soares HP, Young SH, Eibl G, et al. Dose-dependent AMPK-dependent and independent mechanisms of berberine and metformin inhibition of mTORC1, ERK, DNA synthesis and proliferation in pancreatic cancer cells. PloS ONE 2014; 9(12):e114573. doi: http://dx.doi.org/10.1371/journal.pone.011457310.1371/journal.pone.0114573426241725493642Search in Google Scholar

20. Wang N, Feng Y, Zhu M, Tsang CM, Man K, Tong Y, et al. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem 2010; 111(6):1426-36. doi: http://dx.doi.org/10.1002/jcb.2286910.1002/jcb.2286920830746Search in Google Scholar

21. Rad SZK, Rameshrad M, Hosseinzadeh H. Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine: a review. Iran J Basic Med Sci 2017; 20(5):516. doi: http://dx.doi.org/10.22038/ijbms.2017.8676Search in Google Scholar

22. Liu C-S, Zheng Y-R, Zhang Y-F, Long X-Y. Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia 2016; 109:274-82. doi: http://dx.doi.org/j.fitote.2016.02.00110.1016/j.fitote.2016.02.00126851175Search in Google Scholar

23. Bargiotas P, Konitsiotis S. Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments. Neuropsych Dis Treat 2013; 9:1605. doi: http://dx.doi.org/10.2147/NDT.S3669310.2147/NDT.S36693380815224174877Search in Google Scholar

Polecane artykuły z Trend MD

Zaplanuj zdalną konferencję ze Sciendo